Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Oki

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developing novel strategies to target B-cell malignanciesNathan Fowler, Yasuhiro Oki
Frontiers in Oncology|May 16, 2018
Novel Immunotherapy Options for Extranodal NK/T-Cell LymphomaBoyu Hu, Yasuhiro Oki
Haematologica|May 10, 2007
Endothelial progenitor cells in non-Hodgkin's lymphomaYasuhiro Oki, Anas Younes
Expert Opinion on Biological Therapy|March 21, 2012
Brentuximab vedotin in systemic T-cell lymphomaYasuhiro Oki, Anas Younes
Leukemia & Lymphoma|May 3, 2008
Current role of gemcitabine in the treatment of Hodgkin lymphomaYasuhiro Oki, Anas Younes
Cancer Treatment and Research|January 1, 2019
NK-Cell LymphomasDai Chihara, Yasuhiro Oki
Current Hematologic Malignancy Reports|May 22, 2010
Does rituximab have a place in treating classic hodgkin lymphoma?Yasuhiro Oki, Anas Younes
Expert Opinion on Biological Therapy|September 10, 2014
Brentuximab vedotin for treatment of systemic T-cell lymphomaDai Chihara, Yasuhiro Oki
Current Hematologic Malignancy Reports|January 29, 2018
Central Nervous System Involvement in Peripheral T Cell LymphomaDai Chihara, Yasuhiro Oki
Expert Review of Vaccines|July 24, 2004
Heat shock protein-based cancer vaccinesYasuhiro Oki, Anas Younes
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Developing novel strategies to target B-cell malignanciesNathan Fowler, Yasuhiro Oki
Frontiers in Oncology|May 16, 2018
Novel Immunotherapy Options for Extranodal NK/T-Cell LymphomaBoyu Hu, Yasuhiro Oki
Haematologica|May 10, 2007
Endothelial progenitor cells in non-Hodgkin's lymphomaYasuhiro Oki, Anas Younes
Expert Opinion on Biological Therapy|March 21, 2012
Brentuximab vedotin in systemic T-cell lymphomaYasuhiro Oki, Anas Younes
Leukemia & Lymphoma|May 3, 2008
Current role of gemcitabine in the treatment of Hodgkin lymphomaYasuhiro Oki, Anas Younes
Cancer Treatment and Research|January 1, 2019
NK-Cell LymphomasDai Chihara, Yasuhiro Oki
Current Hematologic Malignancy Reports|May 22, 2010
Does rituximab have a place in treating classic hodgkin lymphoma?Yasuhiro Oki, Anas Younes
Expert Opinion on Biological Therapy|September 10, 2014
Brentuximab vedotin for treatment of systemic T-cell lymphomaDai Chihara, Yasuhiro Oki
Current Hematologic Malignancy Reports|January 29, 2018
Central Nervous System Involvement in Peripheral T Cell LymphomaDai Chihara, Yasuhiro Oki
Expert Review of Vaccines|July 24, 2004
Heat shock protein-based cancer vaccinesYasuhiro Oki, Anas Younes
Pageof 17